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Abstract
Neurons communicate with other cells to elicit outputs that include memory and
movement. Cells, including neurons, create proteins every day for specific functions and in
particular, neurons produce proteins that enable their communication. Proteins found in cellular
membranes are synthesized at the endoplasmic reticulum (ER). However, up to 30% of new
proteins are improperly folded and must be removed from the cell. A build-up of misfolded
proteins can trigger the Unfolded Protein Response (UPR) which initiates other pathways of
protein quality control and can determine the fate of a cell. ER-associated protein degradation
(ERAD) is a ubiquitin-dependent process in eukaryotic cells that helps alleviate protein
accumulation by breaking down misfolded proteins and targeting them to for degradation at the
proteasome. The ERAD system is well described in yeast but is less well studied in multicellular
systems. We used Caenorhabditis elegans (C. elegans) as a model organism to examine the
trafficking of a single transmembrane protein through the ER under stressed conditions and as
part of the ERAD pathway. The glutamate receptor, GLR-1, is a model membrane protein
expressed in a subset of interneurons in C. elegans at the ventral nerve cord (VNC) to observe if
GLR-1 is a candidate substrate for ERAD. Assessing GLR-1’s accumulation in the absence of
ERAD E3 ubiquitin ligases in C. elegans can determine the protein’s regulation in ERAD. Three
putative ERAD E3 ligases in C. elegans are: HRD-1, MARC-6, and HRDL-1. Previous results
showed that deletion of most of the gene encoding HRDL-1, caused an increased accumulation
of GLR-1::GFP in the VNC. HRDL-1 may have a role in regulating GLR-1 degradation at the
ER and GLR-1 may be a candidate endogenous substrate for ERAD. In order to understand how
ERAD effects GLR-1, we used a chemical stressor, tunicamycin, which blocks ER-dependent
glycosylation and initiates the UPR. Tunicamycin treatment induces ER stress, which activates a
UPR-reporter construct hsp-4p::GFP in C. elegans. The hsp4p::GFP reporter responds to
iv

tunicamycin at lower doses when animals harbor the mutation gene hrdl-1. We used quantitative
fluorescence imaging and immunoblotting to determine whether the GLR-1::GFP accumulated
due to underlying ER stress caused by the lack of HRDL-1. Contrary to previous results, we
found no difference in fluorescently-tagged GLR-1 in the VNC in animals lacking hrdl-1, though
overall levels of tagged GLR-1 were increased. GLR-1 with a point mutation that caused ER
accumulation was not affected by the loss of hrdl-1. We propose that another ER E3 ligase may
be involved in GLR-1’s regulation in the VNC that further investigation of cell bodies may
uncover mechanisms of GLR-1 regulation at the ER.
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Introduction
Cells create proteins for specific functions necessary for an organism’s survival.
However, some proteins are improperly folded and must be removed to prevent abnormalities.
The cell has a control system to remove nascent proteins that have failed to fold or assemble
properly (Fujita et al., 2007; Cooper, 2000). The control system is the unfolded protein response
(UPR). Part of the UPR is a mechanism that takes place in the ER, where the cell recognizes
cellular stress from an accumulation of misfolded proteins and control stress through selective
degradation (Araki & Nagata, 2011). ER-associated degradation (ERAD), is a process for ER
quality control that targets misfolded proteins in the ER to be ubiquitylated for degradation.
Ubiquitin is a small protein that is expressed in eukaryotes and can be added to target a protein as
a signal to be broken down in the proteasome (Atkin & Paulson, 2014). The proteasome is a
protein complex that breaks down proteins into smaller fragments. Studying the pathways that
regulate protein aggregation and reducing cellular stress may help understand the causes of
neurodegenerative disorders, which can be caused by protein aggregation, for example,
Alzheimer’s and Parkinson’s Disease (Mittal et al., 2015).
Using Caenorhabditis elegans (C. elegans) as a model organism may bring new light to
the cellular bases of neurodegenerative disorders (Juo & Kaplan, 2004). Because glutamate
receptors are vital for neural communication, including memory and learning (Rose et al., 2003;
Juo & Kaplan, 2004; Maricq et. al, 1995). C. elegans is a promising model for discovering how
ERAD affects specific neurons and their cell biology. Learning more about the cell biology of C.
elegans neurons and their neurotransmitter receptors under normal as well as stressed or diseased
states can give more insight into the basic functions of the human nervous system at a molecular
level.

The Unfolded Protein Response (UPR) and ER- associated Degradation (ERAD)
The UPR is a response by which proteins at the ER membrane initiate pathways that
upregulate UPR gene expression. The protein chaperone, BiP, plays an important role in the
UPR to control cellular stress in the ER. BiP is a member of the family HSP70 molecular
chaperones involved in quality control and folding of proteins (Gething, 1999). The chaperone
binds to newly synthesized proteins in the ER as well as misfolded proteins to be properly
degraded by the proteasome (Gething, 1999). C. elegans, has an ortholog gene to the mammalian
ER-localized chaperone BiP called hsp-4 (Taylor & Dillin, 2013). The hsp-4 gene can function
as a reporter for UPR activation and can be tracked with activation using Green Fluorescent
protein (GFP) (Taylor & Dillin, 2013; Calfon et al., 2012). However, when unfolded proteins
accumulate in the ER, BiP is crucial for activation of three ER transmembrane proteins to induce
the UPR (Calfon et al., 2012; Xiang et al., 2017).
The activation of UPR genes is dependent upon three ER transmembrane proteins called
IRE1 (Inositol Requiring Enzyme), double-stranded RNA-activated PERK (Protein Kinase-like
ER (PKR) Kinase), and ATF6 (Activating Transcription Factor 6) (Calfon et al., 2002). These
transmembrane proteins are in an inactive state when BiP is bound in unstressed conditions and
BiP is removed when ER stress is induced due to competition of unfolded proteins accumulating
in the ER to be bound to BiP (Carrara et al., 2013). The ER proteins can sense conditions of ER
stress and each has different functions for UPR gene expression (Carrara et al., 2013; Storm et
al., 2016). The UPR's transmembrane sensors are involved to repress the function of protein
synthesis and is the first response to regulate protein homeostasis (Chen & Brandizzi, 2013).
Each transmembrane protein work independently to generate UPR gene expression from their
cytosolic domains (Figure 1, Storm et al., 2016).
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The cytosolic domains of the ER sensors are activated when ER stress is detected. IRE1
RNase cytosolic domain becomes activated through conformational changes to target the X-box
binding protein (Xbp1) mRNA for alternative splicing to activate UPR target genes in the
nucleus of the cell. The UPR genes are encoded for proteins involved in protein folding,
maturation, and degradation (Carrera et al., 2013). PERK's cytosolic domain phosphorylates the
eukaryotic initiation factor 2α (eIF2α) to inhibit protein translation and overload of misfolded
proteins at the ER lumen (Carrara et al., 2013). The last ER sensor in the UPR is ATF6 where it
becomes translocated from the ER to the Golgi to undergo proteolytic cleavage creating a
transcription factor ATF6 p50 (Chen & Brandizzi, 2013; Carrera et al., 2013). The transcription
factor migrates to the nucleus of the cell to initiate the expression of UPR genes. However, the
UPR genes made are responsible for activating responses that determine the fate of the cell
(Figure 1). Prolonged ER stress is associated with induced specific cell death pathways and is
suggested to be a molecular mechanism responsible for human pathological disorders including
neurodegenerative diseases (Dibdiakova et al, 2018). One class of UPR genes that is still under
investigation are those involved with ERAD and the biological process it undergoes.
ERAD involves enzymes to bring ubiquitin to polyubiquitylate a misfolded protein so
that the target protein can be transported to the proteasome and be broken down into smaller
peptides. ERAD is a process that targets misfolded proteins that have failed the "folding cycles"
in the ER (Vembar & Brodsky, 2008). Proteins that do not fold properly can lead to improper
cellular function leading further to disease. The ER has multiple checkpoints for misfolded,
damaged, or incomplete proteins via a process known as the ER quality control (Vembar &
Brodsky, 2008; Figure 2). When misfolded proteins are identified, ERAD is initiated to target
these proteins and are marked for degradation with a protein called ubiquitin. Inactivation of
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ERAD leads to an accumulation of misfolded luminal and membrane proteins that can induce ER
stress such as heat shock or chemical stress (Walter & Ron, 2011). The process of ERAD is
important for proteins to be properly refolded or degraded via ubiquitination.
In eukaryotic cells, ERAD uses a polyubiquitination to target misfolded proteins in the
ER creating a ubiquitin chain to be targeted and broken down by the proteasome. Ubiquitin is a
small protein that involves E1, E2, and E3 ligases for protein degradation in the ERAD pathway
(Alberts et al., 2014; Figure 3). Ubiquitin participates in an enzymatic cascade that is initiated by
an E1 ubiquitin-activating enzyme (E1) (Hershko et al., 1980). After activation, ubiquitin is
transferred by an E2 ubiquitin-conjugating enzyme (E2). Finally, ubiquitin becomes attached to a
substrate protein from an E3 ubiquitin ligase (E3). This creates a ubiquitin chain that directs the
misfolded protein to be degraded in the proteasome at the cytoplasm of the cell (Haas et al.,
1982; Woelk et al., 2007; Figure 3). The proteasome breaks down the protein into smaller
fragments or peptides. Thus, ERAD helps re-establish protein homeostasis for the cell after the
involvement of the UPR and E3 ligases by removing accumulated, misfolded proteins from the
ER (Shen et al., 2004).
In ERAD, E3 ligases are enzymes that recognize misfolded proteins or substrates when
they are retained in the ER. E3 ligases are involved in ER quality control for additional
proofreading for proteins to be properly degraded into small peptides to be refolded correctly
(Meusser et al., 2005). Moreover, E3 ligases play an important role in substrate selection for
misfolded proteins to be properly degraded because there are hundreds of genes specific to target
misfolded proteins (Alberts et al., 2014).
This project focus on a single E3 ligase, HRDL-1, in C. elegans since E3 ligases play an
important role in substrate recognition of misfolded proteins. The C. elegans genome has three
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putative ERAD E3 ubiquitin ligases known as HRD-1, HRDL-1, and MARC-6. Depletion of
these ligases caused delayed growth in the worms using different concentrations of tunicamycin
(Sasagawa et al., 2007). An E3 ligase of interest in C. elegans is HRDL-1 where it may play a
role for protein degradation in ERAD knowing it is an enzyme responsible for protein specificity
and regulation (Sasagawa et al., 2007).
Experimental system
Using C. elegans as a model organism will provide important data for understanding the
process of protein degradation in neurodegenerative diseases and regulation of membrane
proteins. C. elegans is a simple model organism to understand more about single synapses and
neurobiology. C. elegans can easily be manipulated to create mutants with defects in specific
genes and they were the first multicellular organisms to have their genome sequenced (Brenner,
1974). C. elegans have been used as a simple model being identified as nematode worms to
observe behavioral effects of ER stress and understanding the ERAD pathway (Sasagawa et al.,
2007; Taylor & Dillin, 2013). There are 300 neurons identified in the C. elegans nervous system
and a subset of those neurons are orthologous to neurons in the human brain (Brenner, 1974).
These nematode worms can provide useful information to analyze single neurons associated with
protein degradation and understanding pre-diseased states of neurodegenerative disorders.
The C. elegans Glutamate Receptor: GLR-1
The glutamate receptor GLR-1 in C. elegans is a transmembrane protein found in the
AVA interneurons (Wang et al., 2012). GLR-1 is expressed in the interneurons at the ventral
nerve cord (VNC) (Zheng et al., 1999; Hart et al., 1995; Maricq et al., 1995). The glutamate
receptor is orthologous to human AMPA type glutamate receptor subunit GluR1 (GluA1) (Yao
et al., 2011). The neurotransmitter glutamate plays a pivotal role in synaptic transmission,
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synaptic plasticity, and neuronal excitation at the post-synaptic surface (Bissen, et al., 2019). The
receptor, GLR-1, is a good candidate to observe expression at the VNC in C. elegans which can
be tagged with either GFP or Yellow Fluorescent protein (YFP) at the synapse. This can also
help us observe the process of how membrane proteins in neurons are regulated at the ER.
The project is focused on the receptor GLR-1 to understand how it becomes regulated in
the ER and if it is an endogenous substrate for ERAD. Studies found that GLR-1 was regulated
by ubiquitin signaling at the synapse to be endocytosed in neurons located at the VNC (Kowalski
et al., 2011). Once the receptor is internalized from the cell surface, ubiquitinated GLR-1 can
undergo either degradation or deubiquitination from deubiquitinating enzymes (Kowalski et al.,
2011). In other words, removing the ubiquitin chain to prevent the GLR-1 receptor from being
degraded. Another study found that GLR-1 can be recycled to the synapse from endosomes and
can be assembled in a four-part complex in the ER (Brockie et al., 2013). The receptor, GLR-1,
was still expressed in the plasma membrane of the synapse but is not recycled in endosomes.
Structural mutations of GLR-1 were used to observe trafficking of the receptor which led to a
dramatic decrease of GLR-1 expressing at the synapse and retention at the ER (Grunwald &
Kaplan, 2003).
GLR-1 trafficking and export from the ER require components in the UPR signaling
pathway. Studies found that the UPR pathway is required for GLR-1 exit in the ER even with the
absence of ER-stress inducing agents such as heat shock or chemical agent tunicamycin (Shim et
al., 2004). Suggesting there may be a basal-level requirement for UPR signaling. The basal-level
requirement can be the ER sensor IRE-1. The strain sel-1(e1948) in C. elegans a mutant for
ERAD is upregulated by XBP-1 in ER stress and UPR (Shim et al., 2004). To observe the
trafficking of GLR-1 with the sel-1 mutants, the IRE-1/XBP-1 pathway is required for glutamate
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receptor trafficking in ER stress environments. This suggests that GLR-1 may have an essential
role in ERAD in ER stress to observe what components in the quality control system are
necessary for glutamate receptor assembly and activity.
To confirm if GLR-1 is an endogenous substrate of ERAD, stressing the ER with a
chemical stressor can help determine if the receptor is functioning in the pathway. The ER
stressor, tunicamycin, initiates the UPR in C. elegans and induce ER stress in cells. Tunicamycin
is a bacterial toxin that inhibits glycosylation sites in the protein at the ER lumen (Bull & Thiede,
2012; Dibdiakova et al., 2018). Glycosylation is important at the lumen of the ER for proteins to
fold correctly and mature to be transported to the cellular membrane of the cell. This process is
known to generate a diverse amount of proteins and have different properties during folding
(Alberts et al., 2014). Glycosylation inhibition can lead to protein aggregation and cell death
(Dibdiakova et al., 2018). The protein, GLR-1, becomes glycosylated in the ER when it is
properly folded with the help of ER lectin-like chaperones calnexin and calreticulin (Peterson et
al., 1995; Grunwald & Kaplan, 2003). By treating the animals with tunicamycin the process may
be that GLR-1 will not be glycosylated and will therefore be retained in the ER, activating the
ERAD pathway.
A series of experiments done in the Dahlberg lab was conducted observing three E3
ligases in C. elegans (HRDL-1, HRD-1, and MARC-6). Removing the E3 ligase hrdl-1 in C.
elegans, caused increased accumulation of GLR-1::GFP suggesting hrdl-1 has a role in
regulating GLR-1 degradation based on western blotting experiments (Figure 4; Witus, 2016
unpublished data from Honors Thesis). Imaging analysis was conducted between two E3 ligase
mutants: hrd-1 and hrdl-1. The average puncta width (neurites at the VNC) was significantly
wider in hrdl-1 mutants compared to the wildtype expressing GLR-1::GFP supporting that GLR-
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1 is being accumulated in the VNC without functional HRDL-1 (Witus, 2016 unpublished data
from Honors Thesis; Figure 5). These findings suggest that GLR-1 may be an endogenous
substrate for ERAD, however, knowing where the membrane protein is accumulating is still
unclear.
An endoglycosidase H (EndoH) experiment was conducted to determine the location
where GLR-1 is accumulating without functional HRDL-1. The purpose of the EndoH
experiment was to observe GLR-1::GFP glycosylation patterns either at the ER or in the Golgi
apparatus of the cell. Based on the data, the hrdl-1 mutants displayed GLR-1 receptor was being
retained in the ER compared to wildtype GLR-1::GFP (Hassell and Hulsey-Vincent, 2019
unpublished data; Figure 6). This suggests that removing functional HRDL-1 causes GLR-1 to
accumulate in the ER and the pathway the protein is being targeted for degradation may be under
ERAD with a specific ubiquitin E3 ligase HRDL-1. By inducing ER stress to the GLR-1 protein
using a chemical stressor tunicamycin will help determine if the animals carrying the mutant
strain hrdl-1 were initially ER stressed or inducing more stress will develop a severe phenotype.
Using tunicamycin in C. elegans without functional HRDL-1 is a great model to study
whether if GLR-1 is essential for being targeted as misfolded or inactivated. Previous work has
been done to understand the process where tunicamycin induced cellular stress and what
pathway the stressor is activating. In the unfolded protein response, there are three ER sensors:
IRE1, PERK, and ATF6 (strom et. al, 2016). Tunicamycin activates in the IRE-1 pathway to
conduct alternative splicing of XBP-1 a transcription factor for protein quality control and
activate the ERAD pathway (Carerra et. al, 2013 & Taylor and Dillin, 2013).
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Questions and hypotheses

In this study, an ER chemical stressor tunicamycin was used with C. elegans that express
a fluorescent derivative of GLR-1, GLR-1::GFP. The main question we hoped to answer in this
study was: Are the effects of hrdl-1 mutation due to increased ER stress? The question was
subdivided into three questions to help answer if HRDL-1 is an enzyme necessary to maintain
the health of neurons expressing GLR-1 or does it require other proteins to help promote the
function of HRDL-1 for proper GLR-1 degradation.

Q1: Does loss of hrdl-1 sensitize animals to ER stress?
The first aim is directed in the unfolded protein response following the molecular
chaperone BiP using tunicamycin to induce ER stress. The protein BiP or hsp-4 in C. elegans
was used as an indicator when it is activated in the presence of tunicamycin by GFP in a previous
study observing loss of ERAD E3 ligases (Sasagawa et. al, 2007). Using the protein, hsp-4, to
study ER stress, there can be a similar pattern with an ERAD E3 ligase HRDL-1. There are two
hypotheses regarding if the loss of HRDL-1 will sensitize the worms to ER stress. If hrdl-1
mutation causes ER stress on its own, then BiP (hsp-4) should be upregulated under basal
conditions. Meaning without the presence of a chemical stressor. The second hypothesis is to
determine if hrdl-1 mutants become sensitized to ER stress, then BiP (hsp-4) should be
upregulated much more than wildtype in the presence of a stressor (tunicamycin). This question
was addressed discerning if worms carrying the hrdl-1 mutation and expressing hsp-4p::GFP will
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be used as a model to observe ER stress using tunicamycin. The strain hsp-4p::GFP will be used
as a reporter gene for UPR activation in the ER (Taylor & Dillin, 2013).

Q2: Does loss of hrdl-1 in combination with ER stress disrupt GLR-1 regulation?
Work was previously done to observe GLR-1 regulation with the loss of ERAD E3
ligases: HRD-1, HRDL-1, and MARC-6 (Sasagawa, et al., 2007). In prior work on the E3 ligases
in C. elegans, one E3 ligase showed a difference in GLR-1 expression (Witus, 2016 unpublished
data from Honors Thesis). Worms with loss of HRDL-1 showed a greater abundance of GLR1::GFP and had wider puncta expression of the protein at the ventral nerve cord (Witus, 2016
unpublished data from Honors Thesis). The aim is to determine if the animals with hrdl-1
mutation are initially ER stressed or will develop a severe phenotype by inducing ER stress. The
hypothesis is if hrdl-1 mutation in the presence of ER stress disrupts GLR-1 regulation, then
more severe GLR-1 phenotypes will be observed: increase abundance of GLR-1::GFP protein
and different localization than wildtype. This would indicate that GLR-1 is regulated by two
different mechanisms. One that is dependent on hrdl-1 and one that is dependent on ER stress
levels. If we don’t see differences in GLR-1::GFP between wildtype and mutant strains in the
presence of tunicamycin, this would indicate that tunicamycin and the hrdl-1 mutant work in the
same pathway for GLR-1 regulation.

Q3: Does a mutation that affects the structure of GLR-1 with loss of hrdl-1 disrupt protein
regulation at basal conditions?
Disrupting the structure of a protein or receptor to express at the cellular membrane, the
protein will be inactivated and will not be present at its destination either at synapses or in
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membrane bound organelles. Previous work by Grunwald and Kaplan (2003) showed changes at
the ligand binding and pore domains of GLR-1. The mutation at the ligand binding region
prevents GLR-1 from exiting the ER. It is not known if a mutation preventing GLR-1 to exit in
the ER with loss of HRDL-1 will have the same effect based on localization and abundance of
the protein. I hypothesized that if a mutation at the ligand binding site of GLR-1 prevent
regulation of the protein exiting the ER, then the point mutation in hrdl-1 would result GLR-1
phenotypes to have high abundance of GLR-1::YFP and different localization than wildtype.
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Methods

C. elegans maintenance and crossing:
C. elegans strains were grown on Nematode Growth Medium agar (NGM) with
cholesterol, MgSO4, and CaCl2. OP50 E. coli a strain of bacteria was grown on NGM plates as a
food source for the worms. The C. elegans strains (Table 1) were grown in incubators at 20 ̊ C
for 3 days from larval stage to adult worms. To create different genetic hybrids, wild type males
were mated with hermaphrodites that will be homozygous for the allele of interest, for example,
SJ4005 transgenic worms. The F1 males were then mated with hermaphrodites that were
homozygous to the second allele of interest to create strains that were contain two alleles of
interest. The alleles were then followed with another two more generations to obtain worms that
will be homozygous for the desired allele.
The newly made hybrid crosses were tested and confirmed using the Polymerase Chain
Reaction (PCR). The hybrid crosses were hsp-4p::GFP; hrdl-1,GLR-1::GFP; hrdl-1, and GLR1::YFP; hrdl-1 (Table 1). Primers in table 2 were used to detect the mutation of hrdl-1.

Tunicamycin Assay:
Adult L4 stage worms were collected and transferred to experimental plates 5 µg/mL of
tunicamycin containing NGM agar. During preliminary experiments, different concentrations of
tunicamycin were used. The concentrations of tunicamycin were 0 µg/mL, 2 µg/mL, 5 µg/mL,
and 7.5 µg/mL. At 5 µg/mL, changes between genotypes were easily differentiated and was
decided to use 5 µg/mL as an optimal concentration for tunicamycin between genotypes of
interest. A single concentration of tunicamycin was added to the molten NGM agar and a control
plate with ethanol (EtOH). Each plate with 5 µg/mL of tunicamycin and ethanol were allowed to
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cool for at least 8 hours at room temperature and stored in a tub. The next day, 75 µl of cultured
OP-50 Escherichia Coli was added to each treatment plate and was allowed for the bacteria to
grow another 2-3 days. On experiment day, adult worms were washed with M9 buffer and were
collected in Eppendorf tubes. Remaining M9 buffer was removed and 11 µL of concentrated
worms were pipetted to a Whatman Filter paper “stamp”. The worms collected on the “stamp”
were transferred to each treatment plate for 6 hours. After the 6 hours, all the worms’ images
using a fluorescence microscope were captured collecting approximately 15-20 worms from each
treatment. For western blotting, worms were washed with M9 buffer to collect lysates from each
treatment to observe protein abundance of GLR-1 or hsp-4p::GFP (Sasagawa et al., 2007
;Tcherpakov et al., 2008; Darom et al., 2010; Taylor & Dillin, 2013 and Waldherr et al.,2019).

Immunoblotting (Western Blot):

Young adult C. elegans on NGM agar plates or 5 µg/mL tunicamycin were washed into
Eppendorf tubes with M9 solution. M9 buffer was removed from the solution to gather
concentrated worms at the bottom of the Eppendorf tube.4x SDS sample buffer and 100 mM βmercaptoethanol (BME) was added in the tube containing the concentrated worms. The animals
suspended in SDS loading buffer and BME were frozen at -20˚C for storage. Once lysates were
ready to use, 1 mM phenylmethylsulphonyl fluoride (PMSF) protease inhibitor in ethanol was
added to the lysates. The solution was boiled for 2 minutes at 95˚C on a heat block and was
centrifuged at 14k RPM in a microcentrifuge to collect the supernatant. Proteins from the lysate
was separated from a denaturing 8-10% polyacrylamide gel in 1x SDS running buffer and was
then transferred on a nitrocellulose membrane overnight at 4˚C with primary antibodies (Table
3).
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The nitrocellulose membrane was blocked in 5% milk dissolved in Tris buffer for 5
minutes. The blots were incubated in a 1:1000 dilution of primary antibody in 5% milk in TBS
overnight at 4˚C. The membrane was washed 3 times for 5 minutes each in TBS-T. The
nitrocellulose membranes were incubated in a 1:10,000 dilution of secondary antibody (sheep α
mouse or donkey α rabbit) in 5% milk in TBS-T for 3 hours at 4 ˚C. The membranes were
washed 3 times for 5 minutes each in TBS-T. Protein bands was visualized using a
chemiluminescent substrate. Images was acquired using a LI-COR Odyssey Fc imager.

Quantitative analysis of GLR-1::GFP or YFP and hsp-4p::GFP immunoblotting:
ImageStudio® software was used to measure GLR-1::GFP or YFP and free GFP protein
bands. Tubulin was used as a loading control to determine the population of worms collected
from each lysate and to determine the ratio of GLR-1 (~130 kDa) or free GFP (~30 kDa)
expression between genotypes of interest. Wildtype strains were normalized to 1 and mutant
strains were compared based on whether the protein was abundant compared to wildtype. The
statistical analyses to compare GLR-1::GFP or GLR-1::YFP protein abundance were T. tests
between conditions of ethanol and tunicamycin.

Imaging GLR-1::GFP and GLR-1::YFP localization:
All fluorescence imaging in GLR-1::GFP experiments were performed using a
DeltaVision microscope with Olympus IX70 base and a 60x oil UPlan Apo NA 1.4 (oil
immersion) objective equipped with an Xenon lamp to detect GFP or YFP using FITC filter. L4
stage hermaphrodites were paralyzed on glass coverslips in a drop of 30 mg/mL 2,3butanedianoe monoxamine (BDM) in M9 buffer for 5-6 minutes prior to imaging. The
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immobilized worms will be placed on a 2% (w/v) ddH2O agarose pads on glass slides. Images
were captured with a Photometrics HQ2 Cool Snap camera using a SoftWoRx Software with
exposure at 0.600 ms and image field was set as 1024x1024. All ventral nerve cord (VNC)
images in Z-stack (optical section 0.20) were taken in the anterior VNC posterior to the RIG
neuronal cell bodies as a landmark.

Image Analysis of GLR-1::GFP and GLR-1::YFP fluorescence:
Quantitative analysis of the VNC of the worm was accomplished on Z-stacks that were
comprised of 15-20 images and were deconvolved without any saturation to quantitatively
analyze puncta intensity, density, and width. The individual stack images that were out-of-focus
were deleted and condensed into maximum intensity projection using FIJI® an open source
ImageJ program. A macro feature written in FIJI® was used to measure background
fluorescence, puncta width, cord length and number of puncta identified at the VNC (See
Appendix I). To measure puncta width and intensity at the VNC, an adaptive threshold was used
with Phalkansar in FIJI® to help isolate puncta individually. All line scan images to measure
puncta intensity, density, and width were taken mid-anterior at the VNC from the RIG neuronal
cell bodes. Tukey’s HSD statistical analysis for fluorescence quantification was used to test
significant differences between strains for GLR-1::YFP. A Tukey HSD statistical test was used
to compare varying levels of GLR-1::GFP fluorescence between wildtype strain and mutant
strain without the functional HRDL-1 gene in each condition (ethanol or tunicamycin).
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Results

hsp-4p::GFP are more sensitive to tunicamycin compared to wildtype:
To better understand the ER stress inducing agent tunicamycin using hsp-4p::GFP with
hrdl-1 mutants, a dose-response experiment was conducted to compare GFP expression in
wildtype hsp-4p::GFP expressing animals and the E3 ligase mutant animals. Preliminary
experiments were conducted to observe the sensitivity of tunicamycin using the zcIs4 (hsp4p::GFP) and a hrdl-1 mutant strain (zcIs4;hrdl-1(gk28)). The zcIs4 strain has the heat shock
protein-4 (hsp-4) an ortholog of BiP at the promoter that is expressed with GFP (green
fluorescent protein) serving as a reporter gene to observe expression of cellular stress in the UPR
pathway at the ER (Sasagawa et al., 2007; Taylor & Dillin, 2013) (Figure 1 & Figure 15). Based
on the data in Figure 7, the tunicamycin concentration 5µg/mL was a concentration selected to
observe optimal differences between the zcIs4 wildtype and hrdl-1 mutant at 6 hours. The zcIs4;
hrdl-1 mutant strain had increased expression of the hsp-4 gene which indicated that tunicamycin
induced the UPR in the worm (Figure 7). In further experiments, 5µg/mL concentration of
tunicamycin was used to observe GFP protein abundance with hrdl-1 mutation.

hsp-4p::GFP abundance increase without functional hrdl-1:
To confirm that based on levels of high hsp-4p::GFP expression in hrdl-1 mutants
qualitatively, a western blot experiment was conducted. Whole cell lysate of young adult worms
being exposed to either ethanol (vehicle control) or 5 µg/mL of tunicamycin were collected after
6 hours of exposure. Lysates were run on an SDS-PAGE gel and transferred to a nitrocellulose
membrane. Expression of hsp-4p::GFP on ethanol and tunicamycin were probed with anti-GFP
monoclonal antibodies and β-tubulin were probed using anti-β-tubulin as a loading control
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(Figure 8 A). We observed that the zcIs4; hrdl-1 mutants on tunicamycin expressed more GFP
abundance that wildtype significantly (Figure 8 B).
This demonstrates using tunicamycin as a ER stressor to observe the effects of hrdl-1 is
an initial step to use GLR-1::GFP to observe GLR-1 regulation in the ERAD pathway. The hrdl1 gene is a putative loss-of-function mutation (gk28) with a 1981 base pair deletion and it has
been previously demonstrated that the loss of the E3 ligase showed more GLR-1::GFP
abundance with the absence of ER stress (Witus, 2016 unpublished data in Honors Thesis).
Using tunicamycin as an ER stress inducing response in hrdl-1 mutants, data can be predicted to
observe ERAD using GLR-1 and its regulation.

GLR-1::GFP; hrdl-1 does not display a severe phenotype in the presence of tunicamycin
compared with wildtype GLR-1::GFP
GLR-1 is regulated by the IRE-1/XBP-1 pathway (Shim et al., 2004). To confirm that
GLR-1 requires E3 ligase HRDL-1, we aimed to observe if the GLR-1::GFP; hrdl-1 mutants
would display a severe phenotype or will function in the IRE-1 pathway to upregulate UPR
genes for ERAD. To investigate the regulation of GLR-1, tunicamycin an N-linked glycosylation
inhibitor that induces ER stress was used to observe the abundance of GLR-1::GFP between
wildtype and GLR-1::GFP; hrdl-1 mutants (Taylor & Dillin, 2013). Data from Figure 4 was
consistent with the fact that GLR-1::GFP; hrdl-1 mutants displayed more GLR-1 abundance
based on the fold change between wildtype GLR-1::GFP with the absence of ER stress (Figure 9
B). In contrast, there was no difference between wildtype GLR-1::GFP and the hrdl-1 mutant in
the presence of ER stress (Figure 9 B and C). The fold change between GLR-1::GFP on
tunicamycin was 2.56 and GLR-1::GFP; hrdl-1 was 2.36 respectively (Figure 9 B). This data
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may suggest that HRDL-1 may be a candidate substrate for GLR-1 regulation in ERAD.
However, GLR-1::GFP; hrdl-1 mutants did not display a more severe phenotype in the presence
of the ER stressor, which means that loss of hrdl-1 did not further disrupt GLR-1 regulation. The
data presented does not describe where GLR-1 is accumulating either at the cell body of the
neuron or at the synapses because whole cell lysate was collected from each sample. GLR1::GFP localization was taken into consideration as part of our observation of GLR-1 at the
neurites (see below).

GLR-1::GFP localization does not change in the presence of tunicamycin:
After observing there is no significant difference between wildtype GLR-1::GFP and
mutant in ER stress, images mid-anterior at the ventral nerve cord (VNC) were collected to
observe changes in GLR-1 expression (Figure 10). The approach is to observe if the hrdl-1
mutants may present different localization patterns at the VNC compared to wildtype in the
presence of an ER stressor. Images of the worms were captured after 6 hours of tunicamycin or
ethanol exposure. The RIG interneurons were used as a landmark to observe GLR-1::GFP puncta
along the VNC. The VNC was chosen because the ubiquitin-dependent regulation of GLR-1
puncta can be observed here (Burbea et al., 2002). We expect more GLR-1::GFP puncta
expression at the VNC with hrdl-1 in the presence of an ER stressor.
We quantified GLR-1::GFP to observe changes in localization or expression at the VNC
in order to determine if there are changes in GLR-1::GFP wildtype compared to hrdl-1 mutants
in the presence and absence of tunicamycin. The hrdl-1 mutants without the presence of an ER
stressor displayed lower fluorescence than compared to wildtype, but this result was not
significant. In the presence of tunicamycin, the hrdl-1 mutants displayed lower puncta intensity,
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but there was no significant difference with wildtype GLR-1::GFP (Figure 11). However,
observing puncta density and width there were no significant changes between hrdl-1 and
wildtype in the presence of tunicamycin (Figure 11). This may be an indication that hrdl-1 is not
a E3 ligase specific for GLR-1 regulation in ERAD and there may be other postsynaptic
elements being recruited for GLR-1 (Burbea, 2002).
Previous data gathered from GLR-1::GFP and hrdl-1 mutants showed that the puncta
width in hrdl-1 mutants had wider puncta than wildtype without an ER stressor (Figure 5).
However, using our imaging and analysis protocol, we were not able to confirm these data.
Following statistical analysis for puncta intensity, density, and width we did not find any
significant difference between wildtype GLR-1::GFP and hrdl-1 mutants with and without
tunicamycin. Observing the quantification of mean puncta intensity, density, and width; the
regulation of GLR-1 was not disrupted with the loss of hrdl-1 in combination of ER stress at the
VNC. While tunicamycin, puncta width did slightly increase in wildtype GLR-1::GFP as well as
the hrdl-1 mutants, these values were not significantly different (Figure 11). The same trend
applies to puncta density between wildtype and hrdl-1 mutants (Figure 11).

hrdl-1 mutation does not disrupt the regulation and localization of mutant GLR-1 (ligandbinding mutant, E770A)
A ligand binding mutant was used to observe GLR-1 regulation of a receptor that is
trapped at the ER. We crossed the hrdl-1(gk28) allele into nuIs114 GLR-1::YFP and nuIs96
GLR-1(E770A)::YFP (Table 1 & Figure 15). The GLR-1(E770A)::YFP strain is a transgene that
contains KP#685 which the strain has a E770A mutation changing glutamate to alanine
preventing GLR-1 from exiting the ER (Kaplan & Grunwald, 2003). The ligand binding mutant
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has decreased abundance at the synapses compared to wildtype GLR-1::YFP (Kaplan &
Grunwald, 2003). To visualize the distribution of GLR-1::YFP with ligand binding mutant and
hrdl-1 mutant, VNC images were acquired to view differences between both genotypes (Figure
12). Qualitatively, the ligand binding mutant with the hrdl-1 mutation (E770A; hrdl-1) expressed
different GLR-1 abundance comparted to wildtype (Figure 11). The E770A; hrdl-1 mutant
displayed less abundant GLR-1 compared to wildtype, E770A, and hrdl-1. GLR-1::GFP puncta
intensity, density, and width were measured using quantitative fluorescence.
After measuring GLR-1::YFP puncta at the VNC, statistical analysis was conducted to
observe differences in puncta intensity, density, and width between hrdl-1 mutants. Comparing
the puncta intensity with wildtype GLR-1::YFP, the ligand binding mutant E770A and E770A;
hrdl-1 mutant displayed significantly reduced GLR-1 puncta intensity (Figure 13). While GLR1::GFP; hrdl-1 had no significant difference to wildtype. In puncta density, the E770A ligand
binding mutant was the only transgene that displayed significantly denser GLR-1 puncta at the
VNC while the hrdl-1 mutants shared no significant difference to wildtype GLR-1::YFP (Figure
13). Comparing puncta width there was no significant difference between E770A, E770A; hrdl1, and GLR-1::YFP; hrdl-1 to wildtype (Figure 13). The data suggest that hrdl-1 does not disrupt
GLR-1 localization in mutant GLR-1 (E770A). We expect to observe more GLR-1::YFP
abundance in E770A; hrdl-1 mutants, but a different phenotype was observed with less abundant
GLR-1 compared to wildtype and E770A ligand binding mutant.

Mutant GLR-1(E770A)::YFP decrease in abundance with hrdl-1 mutation
To confirm the difference in GLR-1::YFP expression and localization with E770A; hrdl1, a western blot analysis was conducted to observe total GLR-1 abundance. Normalized GLR-
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1::YFP abundance was compared to wildtype and E770A ligand binding mutant with hrdl-1
mutation (Figure 14 A). The GLR-1::YFP; hrdl-1 mutant displayed more abundant GLR-1
compared to wildtype that was expected from previous western blot analysis with GLR-1::GFP
(Figure 9 A). However, the E770A; hrdl-1 mutant displayed less abundant GLR-1 compared to
GLR-1(E770A)::YFP mutant. The low abundance of GLR-1 in E770A; hrdl-1 correlate with the
results observed previously from imaging analysis when comparing to wildtype GLR-1::YFP
(Figure 12 and Figure 14 B). The data presented further supports that a structural mutation at the
ligand binding domain in GLR-1 with hrdl-1 mutation does not further disrupt regulation.
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Discussion

The ERAD system is well described in yeast but is less well studied in multicellular
systems. C. elegans is used as a model organism to examine the trafficking of a single membrane
protein through the ER under stressed conditions in the ERAD pathway. The glutamate receptor
GLR-1 has not been well studied to understand protein regulation in ER stressed conditions in
neurons using C. elegans. In previous work in our lab, the mutation of ERAD E3 ubiquitin ligase
hrdl-1 influenced GLR-1 localization and expression without the presence of an ER stressor. We
followed up this finding using an ER stressor (tunicamycin) and following the abundance and
localization of GLR-1. My results differ from previous results, because I found no difference in
GLR-1 localization in the hrdl-1 mutant, in the presence or absence of tunicamycin. This could
suggest that another E3 ligase in ERAD is upregulated to target misfolded or inactivated GLR-1
protein.
Previous experiments in the Dahlberg lab, one of the three E3 ubiquitin ligases identified,
HRDL-1, may be an enzyme specific for GLR-1 in neurons using C. elegans. Western blot
experiments done to observe GLR-1 abundance showed an accumulation of GLR-1::GFP in
hrdl-1 mutants as did fluorescence microscopy experiments. However, the western blot
experiment also suggest that HRD-1 may have a role in GLR-1 regulation from having the
second most abundant GLR-1::GFP (Figure 4). Further studies are needed to confirm if HRD-1
is another E3 ligase works in concert with HRDL-1 for GLR-1 regulation in ER stress conditions
using double mutants.
Because hrdl-1 displayed a disruption in GLR-1 expression and localization in C. elegans
without the presence of an ER stressor, we wondered whether HRDL-1 is a candidate enzyme for
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GLR-1 regulation in ERAD. We developed an assay to observe the role of hrdl-1 in the presence
of an ER stressor using tunicamycin. The hrdl-1 mutant was crossed with the hsp-4p::GFP
transgene to observe if the mutants are sensitized. Based on the stress response of the hsp4p::GFP; hrdl-1 mutants, we determined that hsp-4 gene activity was moderately upregulated at
basal conditions and highly upregulated at 5 µg/mL of tunicamycin compared to wildtype hsp4p::GFP (Figure 7). This suggests that the hrdl-1 mutants are sensitized to tunicamycin and that
hrdl-1 mutants could serve as a good model for observing role of ERAD in GLR-1 regulation.
Our ER stress experiments with GLR-1 using tunicamycin showed that hrdl-1 mutants
did not display a severe GLR-1 phenotype, which indicates that the hrdl-1 mutants are not
inhibiting normal GLR-1 regulation in ERAD. Our model indicates that tunicamycin initiates the
UPR activating the ER sensor IRE-1 upregulating UPR genes for ERAD causing GLR-1 to
accumulate in the ER because tunicamycin prevents GLR-1 to get glycosylated to be trafficked
out of the ER (Sasagawa et al., 2007; Taylor & Dillin, 2013). But from our results, an E3 ligase
other than HDRL-1 is compensating for the accumulation of GLR-1. Thus, misfolded,
inactivated, or immature GLR-1 receptors are getting ubiquitylated in ER stressed conditions
even with hrdl-1 mutation. In addition, regulation by clathrin-mediated endocytosis seems
unaffected since there was no significant difference in puncta density and width at the neurites at
the VNC in C. elegans (Burbea et al., 2002 and Figure 11). An experiment to confirm the
trafficking of GLR-1 in ER stress conditions is to use the unc-11 gene that encodes a clathrin
adaptin protein AP180 to recruit clathrin for protein trafficking in cells (Burbea et al., 2002).
Another option to explain why GLR-1 displayed no change in regulation in ER stressed
conditions is our use of a novel imaging and analysis protocol. Puncta intensity, density, and
width were measured differently from previous data collected with hrdl-1 mutants in GLR-
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1::GFP background. The imaging analysis done previously used MetaMorph (Version 6.0) to
generate linescans and used a custom written software using Igor Pro (Wavemetrics) to analyze
GLR-1 puncta at the VNC (Dahlberg & Juo, 2014; Kowalski et al., 2011). Our imaging analysis
protocol used a macro feature written in FIJI® to isolate GLR-1 puncta was created than
manually setting up a threshold to isolate the neurites expressed on the VNC. A different image
acquisition and deconvolution was used with the DeltaVision microscope in this study.
Another important way in which image analysis was different was that GLR-1::GFP
puncta mid-anterior at the VNC was observed rather than observing puncta posterior from the
RIG neuronal cell bodies. The data presented in the current experiments show that GLR-1::GFP
puncta mid-anterior at the VNC does not disrupt GLR-1 regulation with the loss of hrdl-1
(Figure 11). However, representative images of GLR-1::GFP between ethanol and tunicamycin,
the GLR-1::GFP; hrdl-1 mutants do show wider GLR-1 puncta than wildtype at the far anterior
of the VNC (Figure 10). Instead of isolating GLR-1 puncta mid-anterior at the VNC and
focusing puncta close to the cell bodies, puncta width data can change between both treatments
(ethanol and tunicamycin) and wildtype. If this result holds true where loss of hrdl-1 does disrupt
GLR-1 regulation based on puncta width and intensity, GLR-1 may be an endogenous substrate
in the ERAD pathway. Meaning, we can expect to observe more GLR-1 localization in the hrdl1 mutants at the VNC and a disruption of GLR-1 regulation.
Because the hrdl-1 mutant did not display a severe phenotype and because there was no
disruption of GLR-1 regulation in ER stress conditions, HRDL-1 may function redundantly with
or downstream of HRD-1 for promoting degradation with misfolded or inactivated proteins. A
study observed the interaction between gp78 (HRDL-1) and Hrd1 (HRD-1) work in concert for
ERAD for both luminal and membrane substrates (Zhang et al., 2015). GLR-1 is a
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transmembrane protein made in the ER and is regulated in ERAD, and could therefore be a target
for luminal or membrane directed ERAD (Rubenstein et al., 2012). In the study, model ERAD
substrates were chosen: TCRα (T-cell receptor α), a type I membrane protein that is
overexpressed in tissue culture cells and major histocompatibility complex (MHC) class I heavychain molecule (MHC 1-147) a luminal protein that require gp78 for degradation (Zhang et al.,
2015). The study suggested that Hrd1 is essential and gp78 can maintain normal ERAD function
if gp78 is permanently deactivated. Also, gp78 functions downstream with the Hrd1 complex
using the BAG6 complex (Zhang et al., 2015). BAG6 is a gp78 interacting chaperone that
facilitates regulation of ERAD substrates to the proteasome for degradation. Taking a closer look
in HRDL-1 (gp78) and the accessory proteins like BAG6 in ERAD can help understand which
protein is important for recruiting a specific E3 ligase in C. elegans. This may be true if
observing hrdl-1; hrd-1 double mutants for GLR-1 regulation in ER stressed conditions.
We wanted to further understand the potential role of HRDL-1 in ERAD using GLR-1 by
preventing intracellular trafficking of the protein. We used ligand binding mutants that prevent
GLR-1 from exiting the ER were used based on an EndoH analysis, which can help determine
where GLR-1 is accumulating with loss of hrdl-1. Based on the glycosylation patterns of GLR1::GFP from animals with the hrdl-1(gk28) mutation, a larger proportion of GLR-1 is retained in
the ER, in the absence of hrdl-1 (Figure 6). We made transgenic strains by crossing GLR-1::YFP
and GLR-1::YFP(E770A), and visualized differences in GLR-1::YFP puncta and protein
abundance (Figure 15 and Table 1). In a study to observe the regulation of GLR-1::YFP,
mutations at the ligand binding and pore domains controlled the exit of glutamate receptors from
the ER in C. elegans (Grunwald & Kaplan, 2003). The ligand-binding mutant (E770A) was
shown to control exit of GLR-1 based on low puncta fluorescence, density, and width compared
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to wildtype GLR-1::YFP (Grunwald & Kaplan, 2003). We hypothesized that the hrdl-1 mutation
would affect GLR-1(E770A) phenotypes, potentially by increasing the abundance of GLR1::YFP. However, the E770A; hrdl-1 mutants expressed less GLR-1::YFP compared to wildtype
and looked the same as the E770A mutant (Figure 12, 13, and 14). This suggest that the loss of
hrdl-1 in E770A ligand-binding mutant does not further disrupt, nor does it rescue, protein
regulation of the glutamate receptor in C. elegans. Importantly, there is also evidence that the ER
does not extend far out of the cell body of the GLR-1 interneurons in C. elegans (Rolls et al.,
2002). During imaging, cell bodies of animals expressing the E770A mutant were extremely
bright—so bright that images had to be taken excluding the cell bodies, in order to enable us to
view VNC puncta. Because the ER is mainly in the cell bodies, when GLR-1 is prevented from
leaving the ER, it will accumulate in cell bodies. It will be important to observe the cell bodies in
C. elegans with the ligand binding mutants to observe differences in GLR-1::YFP expression in
area outside of the VNC (ie, the cell body).
Acquiring images of the ligand binding mutant and E770A; hrdl-1 mutant expressed
brighter cell bodies than wildtype GLR-1::YFP. This can be an important experiment to test
whether GLR-1 is a substrate specific for HRDL-1 in protein regulation and to understand more
about E770A; hrdl-1 phenotype. Because the E770A; hrdl-1 mutant express fewer GLR-1::YFP
expression at the VNC compared to wildtype (Figure 12).
Introducing tunicamycin upregulates the unfolded protein response, which activates
ERAD genes via IRE-1/XBP-1. One ERAD gene in this pathway is the E3 ligase, hrdl-1. In the
absence of hrdl-1, we expected to see evidence that hrdl-1 is important for regulating GLR-1
during ER stress, but we did not. The findings in this study suggests that although a hrdl-1
mutation sensitizes C. elegans to ER stress, via tunicamycin, it does not disrupt GLR-1
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regulation in the presence of that ER stressor. The GLR-1 receptor still has specificity to be
targeted by a specific E3 ubiquitin ligase in ERAD. Indicating that hrdl-1 can work in concert
with another E3 ligase hrd-1 to degrade membrane proteins that are either misfolded or
inactivated in the ERAD pathway in ER stress conditions.
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Future Directions

To clarify the findings of the data with GLR-1::GFP; hrdl-1 mutants in ER stress
conditions, the Dahlberg lab plans to do a re-analysis of the raw data acquired, in the presence
and absence of tunicamycin, to observe most anterior VNC analysis than mid-anterior. This will
help answer whether our differences in findings are due to changes in analysis protocols. In this
case, we would expect to find evidence that GLR-1 regulation is disrupted in animals with the
hrdl-1 mutation, through differences in puncta width. Our new analysis tool will again be used to
observe GLR-1 puncta at the VNC to compare intensity, density, and width most anterior (see
Appendix I).
Another approach is to observe a different E3 ligase (hrd-1) in ERAD to identify if the
loss of one E3 ligase, another E3 ligase can get upregulated for GLR-1 in ER stress conditions.
HRD-1 is another putative ubiquitin E3 ligase for ERAD in C. elegans. There is evidence that
HRD-1 works alongside with BiP (hsp-4) in gonad formation and ERAD (Sasagawa et al.,
2007). Also, HRD-1 may have a role for promoting degradation with misfolded or inactivated
proteins alongside with HRDL-1.
Although hrdl-1 is expected to be upregulated in response to ER stress, there is currently
no evidence for this in the GLR-1-expressing interneurons in C. elegans. One way we could test
if hrdl-1 is downstream of UPR activation (via tunicamycin) is to see whether hrdl-1
transcription is upregulated in response to tunicamycin. Comparing hrdl-1 gene expression to
hsp-4 and hrd-1 expression would allow us to understand if and how these genes are regulated in
response to ER stress in C. elegans. One way to do this would be to construct a new promoter-
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reporter using the promoter of hrdl-1 driving GFP. That would give us information about if the
gene is activated, and in which cells.
In order to determine how ER-retention might be affected by ER stress, we also plan to
repeat our ER stress response experiments with the ligand binding mutant and assay them via
immunoblot and fluorescent image analysis. This approach would allow us to determine whether
inducing ER stress will effect differences in phenotypes for GLR-1(E770A)::YFP expression
and abundance. The Dahlberg lab also plans to cross the ligand binding mutant, in the presence
and absence of the hrdl-1 mutation, with hrd-1 to create novel single and double mutants with
which to explore the roles of those two E3 ligases in ERAD for GLR-1 regulation.
Furthermore, it is also important to investigate the appearance of the interneuron cell
bodies that have increased intensity in ligand binding mutants. Both GLR-1(E770A)::YFP and
E770A; hrdl-1 have cell bodies with increased fluorescence (Figure 12). More importantly,
E770A mutants show increased puncta density (of GLR-1::YFP) at the VNC compared with
wild-type GLR-1::YFP animals, while E770A; hrdl-1 animals do not. hrdl-1 could be a factor in
neuronal development. For example, one study focused on a kinase CDK5, a cyclin-dependent
kinase for neuronal development and the kinase regulates the abundance of GLR-1 at the VNC
(Juo et al., 2007; Monteiro et al., 2012). Loss of CDK5 activity resulted a decreased abundance
of GLR-1 at the VNC and an accumulation of the glutamate receptor in neuronal cell bodies (Juo
et al., 2007). Crossing the ligand binding mutants and/or hrdl-1 mutants with cdk-5 mutants
could help further our understanding about the regulation of GLR-1.
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Figure 1. UPR gene expression pathways from IRE1, PERK, and ATF6 ER stress sensors. Each
sensor is the first response to initiate the UPR to relieve proteins accumulating in the ER and
allow BiP to bind to the misfolded protein (Storm et al., 2016).
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Figure 2. Figure 2 The step-by-step process of ER-associated degradation (ERAD). a. Protein
recognition were cytoplasmic or luminal chaperones in the ER come in to recognize misfolded
proteins. b. Protein targeting for ERAD to target misfolded proteins to the retrotranslocon or ER
ligases. c. Retrotranslocon initiation for proteins to be ubiquitinated. Once ubiquitinated,
misfolded proteins/substrates will be degraded from the proteasome. e. Proteasome targets and
degrades tagged misfolded proteins. The misfolded protein is broken down into peptides (Figure
used with permission from Vembar and Brodsky, 2008).
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Figure 3. Ubiquitin-mediated degradation pathway where a misfolded protein becomes tagged by
ubiquitin with the help of ligases to be degraded by the proteasome. The misfolded protein is
broken down into protein fragments and then to amino acids to be refolded once again.
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Figure 4. Western Blot representative image displaying GLR-1::GFP is affected by mutation of
ERAD E3 ubiquitin ligases. The hrdl-1 mutant expresses more protein abundance of GLR-1
compared to the last two E3 ubiquitin ligases (Witus, 2016 unpublished data in Honors Thesis).
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nuIs24

nuIs24

nuIs24;hrd-1 nuIs24:hrdl-1

nuIs24;hrd-1 nuIs24:hrdl-1

Figure 5 Ventral Nerve Cord (VNC) imaging analysis displaying GLR-1::GFP in C. elegans is
regulated by hrdl-1 an ERAD E3 ubiquitin ligase. (Witus, 2016 unpublished data in Honors
Thesis). GLR-1::GFP images were taken anterior of the worm at the VNC comparing puncta
abundance from wildtype (nuIs24).
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A

GLR-1::GFP

B

GLR-1::GFP;hrdl-1

α GFP
~ 135 kDa

GLR-1::GFP

GLR-1::GFP;hrdl-1

Figure 6. Endoglycosidase H (Endo H) analysis to observe GLR-1::GFP glycosylation patterns
with and without functional hrdl-1. A) Wildtype animals displayed GLR-1::GFP to be
glycosylated and hrdl-1 mutants did not. (B) Density ratio was measured to observe upper and
lower bands (blue arrows) between wildtype and hrdl-1 mutants. The hrdl-1 mutants displayed
misfolded GLR-1 receptor to be retained in the ER.
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Wildtype (N2)

zcIs4 (hsp-4p::GFP)

zcIs4;hrdl-1

Figure 7. The ER stress reporter hsp-4p::GFP is active in the presence of high concentrations of
tunicamycin. Animals that have the hsp-4p::GFP reporter with the mutant gene hrdl-1 respond to
tunicamycin at lower doses of tunicamycin.
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β-tubulin

GFP

Figure 8. Western blot of hsp-4p::GFP and tubulin as a loading control. A) zcIs4; hrdl-1 mutants
showed more GFP in the presence of tunicamycin compared to zcIs4 and N2. B) Normalized
protein levels of zcIs4 and zcIs4; hrdl-1. zcIs4; hrdl-1 mutants had 30x more GFP without
functional HRDL-1. Ethanol was used as a vehicle control to compare with tunicamycin………
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Figure 9. Western blot measuring GLR-1::GFP abundance in wildtype and hrdl-1 mutants +/tunicamycin. A) Whole cell lysate was obtained from both ethanol (vehicle control) and 5 µg/mL
of tunicamycin. Blots were incubated with GFP monoclonal antibodies to probe GLR-1::GFP
abundance (top) and anti-β-tubulin polyclonal antibodies as loading control (bottom). B) Table
of average normalized ratio of GLR-1::GFP to observe fold change between hrdl-1 mutants and
wildtype with tunicamycin. C) Fold change of GLR-1::GFP between wildtype and hrdl-1
mutants with and without tunicamycin. Results were shown relative to fold change levels of
GLR-1::GFP abundance with error bars indicating standard deviation.
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GLR-1::GFP

Ethanol

GLR-1::GFP

Tunicamycin

GLR-1::GFP;hrdl-1

Ethanol

GLR-1::GFP;hrdl-1

Tunicamycin

Figure 10 Representative ventral nerve cord (VNC) images of hrdl-1 mutants in GLR-1::GFP
background with tunicamycin and an image close up of the puncta below each image (zoom
factor: 200%) (GLR-1::GFP ethanol n= 15, GLR-1::GFP tunicamycin n= 16, GLR-1::GFP; hrdl1 ethanol n= 17, and GLR-1::GFP; hrdl-1 tunicamycin n= 24). 95% ethanol was used as a
vehicle control to compare between genotypes. Images were taken on the DeltaVision at 60X oil
objective magnification. Images set at maximum intensity on FIJI® to observe puncta
fluorescence.
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Puncta Density (puncta/µm)

Figure 11. Quantification of mean puncta intensity, density, and width between wildtype GLR1::GFP and hrdl-1 mutant. A Tukey HSD test was calculated between genotype and treatment.
Error bars represent standard deviation. L4 stage worms were randomly selected and imaged per
strain on the DeltaVision and quantified via FIJI® analysis. Error bars represent standard error.
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Figure 12. Representative ventral nerve cord (VNC) images of hrdl-1mutants and ligand-binding
mutant in GLR-1::YFP background (Wildtype n= 20, hrdl-1 n= 18, E770A n= 17, and E770A;
hrdl-1 n= 18). Images taken on DeltaVision at 60X oil objective magnification and image close
up of the puncta below each image (zoom factor: 200%). Images set at maximum intensity on
FIJI® and brightness are adjusted to enable fluorescence viewing between each genotype. Each
image displayed localization patterns observed between wildtype and hrdl-1 mutant.
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Puncta Density (puncta/µm)

Figure 13. Quantification of mean puncta intensity, density, and width from hrdl-1 mutants in
GLR-1::YFP background. Strains analyzed were wildtype (GLR-1::YFP), hrdl-1, E770A, and
E770A; hrdl-1. L4 stage worms were randomly selected and imaged per strain on the DeltaVision
and quantified via FIJI® analysis. Error bars represent standard error. *** = p < 0.001 and * = p
< 0.05 in comparison to wildtype followed by Tukey’s HSD test.
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A

B

Figure 14. Western blot analysis measuring GLR-1::YFP and hrdl-1 mutants. GLR1(E770A)::YFP is the ligand- binding mutant preventing glutamate from binding. Whole cell
lysate was collected from a mixed population of developmental staged animals. Blots were
incubated with anti-GFP antibodies to probe GLR-1::YFP abundance (top) and anti-β-tubulin
antibodies (bottom). Quantification indicates fold change between GLR-1::YFP abundance and βtubulin as a loading control. A) Comparing normalized GLR-1::YFP between wildtype and ligand
binding mutant with hrdl-1. B) Comparing normalized values for GLR-1::YFP for all three
genotypes against wildtype GLR-1::YFP.
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Figure 15. Genetic maps of strains used in this study. hsp-4p::GFP is a transgenic strain used as a
reporter gene of hsp-4 in ER stress conditions. GLR-1::GFP is a transgene with a glr-1 promoter
with a fusion reporter to observe expression of GLR-1. GLR-1::YFP contains a fusion reporter of
yellow fluorescent protein (YFP) for expression of GLR-1. GLR-1(E770A)::YFP a transgene with
a E770A amino acid change at glr-1 promoter creating a structural mutation of GLR-1 at the ligand
binding domain. Hrdl-1 (gk28) is a E3 ligase harboring a 1981 base pair deletion in the first 5
exons and is crossed with all four of the transgenes to observe protein regulation in ERAD.
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Strain name

Genotype

Description

Bristol N2

Wildtype

Wild type strain used to create all other
strains

SJ4005

zcIs4

hsp-4::GFP is an ER stress reporter. Worms
express low levels of GFP at basal conditions
at the gut and hypodermis. GFP increase in
the presence of tunicamycin

hsp-4p::GFP

FJ354

nuIs24
Pglr-1::GLR-1::GFP

Glutamate receptor-1 (glr-1) fused with GFP
located at the ventral nerve cord

hrdl-1*6(gk28)

hrdl-1 putative null allele and E3 mutant.
Strain crossed with SJ4005, CLD83, and
CLD84

FJ864

nuIs24; hrdl-1*6(gk28)

Transgenic worm strain created by Dr. Lina
Dahlberg. The strain does not have the
functional E3 ligase HRDL-1 and has
expressed GLR-1::GFP

KP2592

nuIs114

Wildtype GLR-1 receptor protein to compare
with the ligand-binding mutants known to be
retained in the ER. The receptor is tagged
with yellow fluorescent protein

FJ863
F26E4.11
(gk28)

GLR-1::YFP

KP2267

nuIs96
GLR-1[E770A]::YFP

Ligand binding mutant containing an amino
acid change from glutamate to alanine. GLR1 receptor known to retain in the ER.

CLD 77

hsp-4p::GFP; hrdl-1*6(gk28) hrdl-1 in hsp-4p::GFP background used for
tunicamycin assays

CLD83

nuIs114; hrdl-1*6 (gk28)

hrdl-1 in GLR-1::YFP background

CLD84

nuIs96; hrdl-1*6 (gk28)

hrdl-1 in GLR-1[E770A]::YFP background

Table 1. List of C. elegans strains used in the study. Strain name, genotype, and description to
provide background information about each strain and their purpose in the study.
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Primer name

Primer sequence

Gene detection

ama-1
(Forward)

5’ GGATGGAATGTGGGTTGAGAATCAG 3’

ama-1
(Reverse)

5’CGCACAACGTCTTCCGAG 3’

GFP-start
(Forward)

5’ CGGCTAGCAAAGCAAAGGAGAAGAAC 3’

GFP-NOT
(Reverse)

5’ ACCCTAGCGGCCGGTATAGTTCATCC 3’

LD51(gk28)
(Reverse)

5’GTGTGCCCGGACAATGCTTC 3’

hrdl-13-16
(Forward)

5’ CGCTCCGATGTTACGCGTCG 3’

ama-1 used as control
primers

Green Fluorescent
Protein (GFP) to
determine animals
tagged with GFP
hrdl-1 to screen mutant
hybrids from genetic
crossing

Table 2. Primers used for detecting a mutation with E3 ligase gene hrdl-1 when crossing
mutation in hsp-4p::GFP, GLR-1::GFP, and GLR-1::YFP background.
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Antibody name

Antibody type

Antibody species

Antibody isotype

Detection

JL-8

Monoclonal
primary antibody

Mouse

IgG

GFP

β-tubulin

Polyclonal
primary antibody

Rabbit

IgG

β-tubulin

Sheep α mouse

Secondary
antibody

Sheep

IgG

Fluorescent
tag to JL-8
antibody

Donkey

IgG

Fluorescent
tag to βtubulin
antibody

HRP conjugate
Donkey αrabbit

Secondary
antibody
HRP conjugate

Table 3. Antibodies used for Western Blotting with GLR-1::GFP, GLR-1::YFP, and free GFP. βtubulin was used as a loading control and abundance ratio to GLR-1 or free GFP.
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Appendix I:

Quantitative analysis of C. elegans GLR-1::GFP synaptic puncta
using ImageJ/Fiji
Neriah Alvinez, Nick Galati, Caroline Dahlberg

A

B

C

Figure 1: (A) A line selection is manually selected over a segment of interest in the ventral
nerve cord to measure GLR-1::GFP puncta parameters. This allows exclusion of much of the
background fluorescence. (B) Comparisons of different Gaussian blur and auto local threshold
radii were done to analyze accuracy of size and detection of puncta among varying Gaussian blur
and auto local threshold radius. This was repeated across 3 other images. (C) The optimal
readout of data from selection made after the FIJI macro applied Gaussian blur sigma of 0.75,
Phansalkar Auto Local threshold algorithm with a radius of 2.0, and Watershed.
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Description
The quantitative analysis of synaptic puncta can allow us to identify genotypes that affect neural
synapse pattern and morphology. We observe the glutamate receptor GLR-1 fused to green
fluorescent protein (GLR-1::GFP) to understand the effects of ubiquitin-mediated degradation on
an interneuron receptor (Dahlberg & Juo, 2014). Prior GLR-1::GFP analyses used the custom
puncta program in Igor Pro (Dittman & Kaplan, 2006), but because it relies on proprietary
software, it may not be accessible to all researchers. We currently approach puncta analysis using
auto local thresholding in the free, open source ImageJ program run as the distribution FIJI,
(Schindelin et al. 2012) allowing for a reproducible and less-biased data readout for puncta
analysis.

To facilitate semi-automatic analyses of fluorescent puncta from live-imaged stacks, we created
a macro in ImageJ. This allows us to create a segmented line down the ventral nerve cord of the
animal and enables analyses of animals that are in curved or straight orientations (Figure 1A).
We can then define a spline pixel width that is closest to the puncta to exclude more background
fluorescence. The macro then filters the data with a Gaussian Blur to allow the auto local
threshold Phansalkar to accurately detect puncta while the Watershed filter separates puncta in
close proximity. The macro also generates drawings of the filtered data, allowing users to double
check the puncta detection accuracy (Figure 1B).

Through comparing various Gaussian blur sigma values and auto local threshold radii among
three different images, we determined a blur sigma of 0.75 and threshold radius of 2.0 to be
optimal with a line selection closest to the ventral nerve cord (Figure 1BC). The resulting
measurements that are taken allow users to calculate puncta density, fluorescence intensity, area,
and width of the puncta. The source code can be modified to suit other puncta data similar to
GLR-1::GFP, such as synaptobrevin-1 (SNB-1). Users can change resulting measurements taken,
adjust blur sigma and auto local threshold radius, and the line selection is adjustable upon
starting the macro program.

The macro code and written protocol are available here (at some dropbox link).
A video tutorial is available on YouTube (at some link that will be here).
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